Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • Resource and Technical Advances
    • Clinical Medicine
    • Reviews
    • Editorials
    • Perspectives
    • Top read articles
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Concise Communication
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Transfers
  • Advertising
  • Job board
  • Contact
Activated cholesterol metabolism is integral for innate macrophage responses by amplifying Myd88 signaling
Sumio Hayakawa, … , Ichiro Manabe, Yumiko Oishi
Sumio Hayakawa, … , Ichiro Manabe, Yumiko Oishi
Published November 22, 2022
Citation Information: JCI Insight. 2022;7(22):e138539. https://doi.org/10.1172/jci.insight.138539.
View: Text | PDF
Research Article Inflammation Vascular biology

Activated cholesterol metabolism is integral for innate macrophage responses by amplifying Myd88 signaling

  • Text
  • PDF
Abstract

Recent studies have shown that cellular metabolism is tightly linked to the regulation of immune cells. Here, we show that activation of cholesterol metabolism, involving cholesterol uptake, synthesis, and autophagy/lipophagy, is integral to innate immune responses in macrophages. In particular, cholesterol accumulation within endosomes and lysosomes is a hallmark of the cellular cholesterol dynamics elicited by Toll-like receptor 4 activation and is required for amplification of myeloid differentiation primary response 88 (Myd88) signaling. Mechanistically, Myd88 binds cholesterol via its CLR recognition/interaction amino acid consensus domain, which promotes the protein’s self-oligomerization. Moreover, a novel supramolecular compound, polyrotaxane (PRX), inhibited Myd88‑dependent inflammatory macrophage activation by decreasing endolysosomal cholesterol via promotion of cholesterol trafficking and efflux. PRX activated liver X receptor, which led to upregulation of ATP binding cassette transporter A1, thereby promoting cholesterol efflux. PRX also inhibited atherogenesis in Ldlr–/– mice. In humans, cholesterol levels in circulating monocytes correlated positively with the severity of atherosclerosis. These findings demonstrate that dynamic changes in cholesterol metabolism are mechanistically linked to Myd88‑dependent inflammatory programs in macrophages and support the notion that cellular cholesterol metabolism is integral to innate activation of macrophages and is a potential therapeutic and diagnostic target for inflammatory diseases.

Authors

Sumio Hayakawa, Atsushi Tamura, Nikita Nikiforov, Hiroyuki Koike, Fujimi Kudo, Yinglan Cheng, Takuro Miyazaki, Marina Kubekina, Tatiana V. Kirichenko, Alexander N. Orekhov, Nobuhiko Yui, Ichiro Manabe, Yumiko Oishi

×

Figure 5

Cholesterol binding to the Myd88 CRAC domain is required for signal amplification.

Options: View larger image (or click on image) Download as PowerPoint
Cholesterol binding to the Myd88 CRAC domain is required for signal ampl...
(A) HEK293T cells were transfected with plasmids encoding WT Myd88 or the indicated Myd88 mutant and a NF-κB motif-driven luciferase reporter plasmid (NFκB-Luc). Luciferase activity was normalized to that of cells transfected with a WT Myd88 expression vector. n = 3/group. *P < 0.05 vs. cells transfected with control plasmid. #P < 0.05 vs. cells transfected with plasmids encoding WT Myd88. Tukey-Kramer post hoc test. Data are representative of 3 independent experiments. (B) Affinity-purified, recombinant GST-tagged Myd88 (WT), Myd88 (Y227F), or GST was incubated with 3H-cholesterol (10 μM) as shown in Figure 4B. GST-Myd88 or GST was recovered, and radioactivity was measured. n = 3. *P < 0.05. Tukey-Kramer post hoc test. (C) Whole-cell lysates were collected from control and Myd88-Y227F mutant RAW cells, stimulated for 4 hours with or without LPS, subjected to Native PAGE, and blotted with an anti-Myd88 antibody. Bands with a slower migration rate correspond to the oligomerized form of Myd88 proteins. A photograph of the same protein run on an SDS-PAGE gel and blotted with anti-Myd88 antibody is shown as a control at the bottom. Data shown are representative of 3 independent experiments. (D) Control and Myd88-Y227F mutant RAW cells were stimulated for 4 hours with LPS, after which expression of Il6 and Il1b was analyzed with qPCR. n = 3/group. *P < 0.05 vs. LPS-untreated control cells, #P < 0.05 vs. LPS-treated control cells. Tukey-Kramer post hoc test. (E) GSEA of MSigDB hallmark gene sets and GO Myd88-dependent TLR signaling pathways. RNA-Seq results for control and Y227F mutant cells stimulated with LPS for 4 hours were used. Shown are the gene sets downregulated (FDR < 0.05) in the Y227F cells. An enrichment plot of Myd88 pathway is also shown. No gene sets were upregulated (FDR < 0.05). Data shown as mean ± SD in all panels where P values are shown.

Copyright © 2023 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts